The Caidya Story: Adaptability for a Dynamic Industry

Barbara Lopez Kunz, CEO of Caidya, explains how adaptability enables clinical trial teams to respond to scientific innovation, evolving evidence, and complex regulatory expectations. She describes why novel interventions may require unique protocols or adjustments as teams learn more about a product and its patient population. Through active communication with sponsors, Caidya can recognize new data, reassess plans, and change direction when warranted. The discussion also explores what “adapting at the speed of science” means in practice: combining expertise, teamwork, regulatory understanding, and agility to navigate trial complexity and help sponsors generate the data and guidance needed to advance potential treatments to patients.